-
Pharma watch: Delayed vaccine decisions, insulin price lawsuit, drug cap win
Updates on US pharmaceutical policy, compliance, and regulation.
-
Block fined $40m as NY takes aim at fintech compliance failures
The fintech firm behind Cash App faces regulatory heat over anti-money laundering lapses and crypto oversight shortcomings.
-
How tariffs are reshaping the US pharmaceutical industry
President Trump’s broad 10% tariff push spares pharma for now, but global supply chains may not stay immune.
-
AI update: Regulation in US and Canada, new AI institute in academia
In this roundup, we highlight the latest developments in artificial intelligence policy and practice.
-
US regulatory update: Crypto, climate, and the CFPB
Here’s a summary of the most significant recent developments in US financial regulation.
-
FinCEN ends beneficial ownership reporting mandates for US firms
FinCEN removes beneficial ownership reporting requirements for US companies and US persons, but introduces new deadlines for foreign ones.
-
Canada tables new regulations on money laundering and terrorist financing
Canada introduces regulations to help prevent money laundering, terrorist financing, and sanctions evasion, and to strengthen beneficial ownership transparency.
-
SEC accuses former CFO of round-trip cash transfer scheme
SEC alleges former CFO lied to auditors and falsified records to inflate Acreage’s year-end cash balance.